NCT00389077View on ClinicalTrials.gov

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

PHASE2CompletedINTERVENTIONAL

Enrollment

558

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2011

Study Completion Date

September 30, 2011

Conditions

TumorsLymphomas

Interventions

DRUG

Perifosine

Perifosine 50 mg tablets

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY